Bristol (BMY) Valuation Declined While Westend Advisors LLC Cut Stake

January 15, 2018 - By Nellie Frank

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Penn Davis Mcfarland stated it has 135,899 shares. Northstar Gp Inc accumulated 7,541 shares. Hartford Fin Mngmt has 2.23% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 69,062 shares. Sii Investments Wi stated it has 18,762 shares. Mengis Capital Mngmt has invested 2.09% in Bristol-Myers Squibb Company (NYSE:BMY). Peak Asset Management Limited Liability has 0.32% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 14,041 shares. Bessemer Group Incorporated stated it has 1.78 million shares or 0.45% of all its holdings. Acadian Asset Limited Liability has 0.01% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 31,753 shares. 160,502 were accumulated by Rhenman & Asset Mngmt. Foster Dykema Cabot & Ma accumulated 10,595 shares or 0.12% of the stock. Argi Investment Ltd holds 0.02% or 5,296 shares. Hallmark Incorporated reported 3,206 shares. 2.75 million were accumulated by Ny State Teachers Retirement System. Voya Investment Mgmt Ltd Llc stated it has 780,026 shares or 0.11% of all its holdings. Whalerock Point Partners Ltd, Rhode Island-based fund reported 33,599 shares.

Since September 6, 2017, it had 1 insider buy, and 2 sales for $646,385 activity. 5,300 shares valued at $335,172 were sold by Lynch Thomas J. Jr. on Tuesday, December 12. $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares were bought by Samuels Theodore R. II.

Westend Advisors Llc decreased its stake in Bristol (BMY) by 4.99% based on its latest 2017Q3 regulatory filing with the SEC. Westend Advisors Llc sold 46,250 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 880,371 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $56.11B, down from 926,621 at the end of the previous reported quarter. Westend Advisors Llc who had been investing in Bristol for a number of months, seems to be less bullish one the $102.80 billion market cap company. The stock increased 0.54% or $0.34 during the last trading session, reaching $62.81. About 5.49M shares traded or 2.42% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 15, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Westend Advisors Llc, which manages about $1139.57 billion US Long portfolio, upped its stake in Ishares Iboxx $ Invest. Grade Corp Bd Etf (LQD) by 4,769 shares to 48,128 shares, valued at $5.83 billion in 2017Q3, according to the filing. It also increased its holding in Vanguard Ftse Pacific Etf (VPL) by 5,395 shares in the quarter, for a total of 37,648 shares, and has risen its stake in Ishares Floating Rate Bond Etf (FLOT).

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 25. They expect $0.67 EPS, up 6.35 % or $0.04 from last year’s $0.63 per share. BMY’s profit will be $1.10 billion for 23.44 P/E if the $0.67 EPS becomes a reality. After $0.75 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -10.67 % negative EPS growth.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: which released: “Bristol-Myers Investors Just Need to Broaden Their Minds: Gadfly” on January 10, 2018, also with their article: “Bristol-Myers Squibb to Take $3 Billion Charge Related to Tax Overhaul” published on January 06, 2018, published: “Bristol-Myers sees $3 billion tax hit in fourth quarter 2017” on January 05, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: and their article: “Ex-Dividend Reminder: Bristol-Myers Squibb, Brixmor Property Group and Kite …” published on January 02, 2018 as well as‘s news article titled: “Pensionfund Sabic Buys Procter & Gamble Co, PepsiCo Inc, Bristol-Myers Squibb …” with publication date: January 02, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Ratings Coverage

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. $62.53’s average target is -0.45% below currents $62.81 stock price. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. Leerink Swann maintained the stock with “Outperform” rating in Monday, October 23 report. The firm has “Neutral” rating given on Friday, October 27 by Credit Suisse. The stock has “Hold” rating by Deutsche Bank on Friday, October 28. The rating was upgraded by Jefferies to “Buy” on Monday, December 19. Barclays Capital maintained the stock with “Equal-Weight” rating in Friday, September 9 report. The rating was initiated by Atlantic Securities with “Underweight” on Friday, December 18. The firm has “Hold” rating given on Thursday, July 14 by Jefferies. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Jefferies on Monday, July 17. The rating was maintained by Jefferies on Thursday, August 27 with “Hold”. Piper Jaffray maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Thursday, July 27. Piper Jaffray has “Hold” rating and $6000 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.